Page last updated: 2024-10-25

deferoxamine and Muscular Diseases

deferoxamine has been researched along with Muscular Diseases in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Muscular Diseases: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.

Research Excerpts

ExcerptRelevanceReference
" Further experience with DFO is needed, both to identify the optimal dosage and to clarify the risks of long-term therapy in patients with renal failure."2.37Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine. ( Coburn, JW; Norris, KC, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sikole, A1
Stojkovski, L1
Cakalaroski, K1
Stojcev, N1
Amitov, V1
Polenakovic, M1
Coburn, JW1
Norris, KC1

Reviews

1 review available for deferoxamine and Muscular Diseases

ArticleYear
Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
    Seminars in nephrology, 1986, Volume: 6, Issue:4 Suppl 1

    Topics: Aluminum; Bone Diseases; Deferoxamine; Hematologic Diseases; Humans; Muscular Diseases; Pain; Risk

1986

Other Studies

1 other study available for deferoxamine and Muscular Diseases

ArticleYear
Successful treatment of soft tissue calcifications in uremia.
    Prilozi, 2006, Volume: 27, Issue:1

    Topics: Buttocks; Calcinosis; Deferoxamine; Diphosphonates; Drug Therapy, Combination; Female; Humans; Kidne

2006